WACC over the last 12 months

Healthcare & Pharmaceuticals May 2025 Jun 2025 Jul 2025 Aug 2025 Sep 2025 Oct 2025 Nov 2025 Dec 2025 Jan 2026 Feb 2026 Mar 2026 Apr 2026 WACC bandwidth WACC average 6,4% 6,4% 6,4% 6,5% 6,5% 6,6% 6,9% 7,1% 7,0% 7,0% 7,3% 6,8%

WACC summary

Healthcare & Pharmaceuticals, April 2026 Beta 0,9 Market risk premium incl. Small Cap Premium 6,5% – 8,0% Cost of equity 6,5% – 7,9% Cost of debt 1,4% Risk free rate 0,60% Credit Spread 1,1% Tax Shield 0,2% Risk free rate 0,60% Cost of equity Cost of debt 6,1% – 7,4% WACC 92,4% Equity ratio 7,6% Debt ratio
Dr. Marc Schmidli, CFA

Questions?

Dr. Marc Schmidli, CFA

PwC | Partner | Deals and Valuation Leader
Office: +41 58 792 1564 | Mobile: +41 79 211 7786
PricewaterhouseCoopers AG
Birchstrasse 160 | Postfach | CH-8050 Zürich
http://www.pwc.ch

Thomas Schneller, CFA

Questions?

Thomas Schneller, CFA

PwC | Director | Deals | Valuation & Modelling
Office: +41 58 792 1519 | Mobile: +41 79 608 4445 | Main: +41 58 792 4400
PricewaterhouseCoopers AG
Birchstrasse 160 | 8050 Zürich | Switzerland
http://www.pwc.ch